Refocusing Medication Prior Authorization on Its Intended Purpose-Reference-Cited by-同舟云学术

Refocusing Medication Prior Authorization on Its Intended Purpose

Published:2020-02-25 Issue:8 Volume:323 Page:703
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Resneck Jack S.¹²

Affiliation:

1. Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco

2. Department of Dermatology, School of Medicine, University of California, San Francisco

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2760654/jama_resneck_2020_vp_190178.pdf

Reference10 articles.

1. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage prescription drug plan population.;Bergeson;J Manag Care Pharm,2013

2. Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid.;Seabury;Am J Manag Care,2014

3. Health care spending in the United States and other high-income countries.;Papanicolas;JAMA,2018

4. Medicare Payment Advisory Commission. Health care spending and the Medicare program: a data book. http://www.medpac.gov/docs/default-source/data-book/jun19_databook_entirereport_sec.pdf?sfvrsn=0. Accessed November 29, 2019.

5. Milliman Inc. Evolution of the use of restrictions in commercial formularies. https://www.milliman.com/uploadedFiles/insight/2016/evolution-restrictions-commercial-formularies.pdf. Accessed November 29, 2019.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prior Authorization Leads to Administrative Burden and Delays in Treatment in Primary Total Joint Arthroplasty Patients;The Journal of Arthroplasty;2024-09

2. Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices;JAMA Ophthalmology;2024-08-01

3. A primer on copay accumulators, copay maximizers, and alternative funding programs;Journal of Managed Care & Specialty Pharmacy;2024-08

4. Urinary Incontinence Medications: Patient-Initiated Concerns in Primary Care;Urogynecology;2024-06-21

5. The State of Hepatitis C Elimination from the Front Lines: A Qualitative Study of Provider-Perceived Gaps to Treatment Initiation;Journal of General Internal Medicine;2024-05-23